Literature DB >> 6385798

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7.

R S Remis, K L MacDonald, L W Riley, N D Puhr, J G Wells, B R Davis, P A Blake, M L Cohen.   

Abstract

After two outbreaks of hemorrhagic colitis associated with a previously unrecognized pathogen, Escherichia coli O157:H7, a surveillance system was established to identify and study sporadic cases of this distinct clinical illness in the United States. Between August 1982 and April 1984, we identified 28 persons from 11 states who met our case definition and whose stool specimens yielded E. coli O157:H7. Patients ranged in age from 1 to 80 years. Seventeen patients required hospitalization. All patients recovered, although one developed hemolytic-uremic syndrome 7 days after the onset of bloody diarrhea. Detection of E. coli O157:H7 in stools from persons with hemorrhagic colitis was highly associated with collection of stool specimens within the first 6 days after onset of illness. All E. coli O157:H7 isolates produced a Vero cytotoxin. Hemorrhagic colitis caused by E. coli O157:H7 is widely distributed in the United States as a sporadic illness; clinicians should be aware of its distinctive clinical presentation, and should collect specimens promptly when the diagnosis is suspected.

Entities:  

Mesh:

Year:  1984        PMID: 6385798     DOI: 10.7326/0003-4819-101-5-624

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  41 in total

1.  Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157.

Authors:  Junko Isobe; Tomoko Shima; Jun-Ichi Kanatani; Keiko Kimata; Miwako Shimizu; Naoto Kobayashi; Tomoko Tanaka; Sunao Iyoda; Makoto Ohnishi; Tetsutaro Sata; Masanori Watahiki
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

Review 2.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

3.  Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis.

Authors:  D H Francis; J E Collins; J R Duimstra
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

4.  Diarrheal disease and DRGs.

Authors:  Peter H Gilligan
Journal:  Clin Microbiol Newsl       Date:  2004-01-22

5.  Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

Authors:  K Ramotar; E Henderson; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II.

Authors:  F P Downes; J H Green; K Greene; N Strockbine; J G Wells; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

7.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves.

Authors:  R A Moxley; D H Francis
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

9.  H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis.

Authors:  J J Farmer; B R Davis
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

10.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.